Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 4 Ovarian Neoplasms 3 Prostatic Neoplasms 2 Multiple Myeloma 2 Lymphoma 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Mouth Neoplasms 1 Melanoma 1 Lung Neoplasms 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1 Hematologic Neoplasms 1 Glioma 1 Glioblastoma 1 Fallopian Tube Neoplasms 1 FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1

Interventions

Temozolomide 41 Radiotherapy 19 Radiation 12 Nivolumab 10 pembrolizumab 8 Magnetic Resonance Spectroscopy 8 Bevacizumab 7 Specimen Handling 6 poly ICLC 4 atezolizumab 4 Lomustine 4 Ipilimumab 4 Surgical Procedures, Operative 3 Photons 3 Immunoglobulin G 3 Disulfides 3 Cyclophosphamide 3 veliparib 2 sargramostim 2 rocakinogene sifuplasmid 2 olaparib 2 niraparib 2 Transurethral Resection of Bladder 2 Surveys and Questionnaires 2 Standard of Care 2 Radiotherapy, Intensity-Modulated 2 Radiosurgery 2 OKN 007 2 Mycophenolic Acid 2 Metformin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Glioblastoma × ipatasertib × Clear all

NCT03673787 2025-05-14

IceCAP

Institute of Cancer Research, United Kingdom

Phase 1/2 Active not recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡